Kazia Therapeutics Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.4% | +84.5% | -48.4% | -18.3% | +52.0% | -12.6% | -24.0% | +0.6% | -15.6% | -12.8% | -49.0% | -34.0% | -29.4% | +0.0% | -48.1% | +890.3% | -23.0% | +1.1% | -21.5% | -24.8% | +8.9% | +151.9% | -38.2% | -21.7% | -23.1% | -71.9% | |
| – | +9.4% | +83.9% | -41.0% | -18.5% | +64.6% | -18.4% | -23.0% | +15.6% | -15.4% | -12.4% | -49.0% | -33.8% | -29.2% | +0.0% | -70.6% | +1,592.5% | -23.6% | -42.9% | -52.5% | -18.6% | +41.2% | +175.9% | -67.9% | +14.0% | -43.0% | -19.7% | |
| – | -2.3% | +111.7% | -34.5% | -22.6% | +87.9% | -19.0% | -48.2% | +62.1% | -29.2% | +19.1% | -54.6% | -60.2% | +38.8% | +0.0% | -70.0% | +1,673.4% | -24.6% | -56.8% | -58.8% | -8.8% | +61.3% | +214.8% | -73.3% | -28.8% | -68.4% | +162.2% | |
| – | -2.3% | +111.7% | -34.5% | -22.6% | +87.9% | -19.0% | -28.8% | +18.0% | -13.1% | -3.0% | -54.6% | -60.2% | +38.8% | +0.0% | -70.0% | +1,673.4% | -24.6% | -56.8% | -58.8% | -8.4% | +60.7% | +214.8% | -73.3% | -28.8% | -68.4% | +162.2% | |
| – | +36.8% | +48.3% | -55.1% | -1.9% | -34.0% | +18.7% | +16.4% | +6.2% | +16.0% | -63.8% | -11.1% | +242.2% | -98.6% | +417.9% | -84.7% | -96.8% | +4,450.0% | -94.4% | -77.7% | +137,739.4% | -100.0% | +17,212.1% | -32.9% | +105.9% | +26.7% | -32.3% | |
| – | +30.0% | +20.0% | -53.1% | -7.7% | +22.0% | -29.7% | +1.1% | -29.3% | -50.6% | -30.8% | +17.0% | -58.1% | – | – | -102.3% | – | – | -100.0% | -100.0% | – | – | -8,400,000.0% | – | – | – | – | |
| – | – | -23.8% | -10.0% | +7.3% | -15.9% | -4.6% | -25.4% | -78.6% | -22.6% | -48.2% | -48.8% | -50.7% | -61.1% | -64.3% | +15.7% | +466.9% | +802.5% | -17.3% | -99.8% | -100.0% | – | – | – | – | – | – | |
| – | – | -24.3% | -3.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.3% | +73.8% | -55.6% | – | – | – | – | – | – | – | – | – | – | – | -22.5% | -29.1% | -40.9% | +1,836.5% | -8.4% | -7.4% | -8.0% | +77.3% | -13.0% | -9.8% | -10.8% | -92.9% | |
| – | +46.5% | +48.3% | -56.9% | +6.7% | +247.3% | -76.1% | -6.4% | +3.4% | +15.1% | +16.9% | -32.6% | +35.9% | -53.4% | +0.0% | -16.1% | -45.3% | -10.8% | +566.6% | -15.5% | -21.6% | +27.5% | +126.4% | -13.0% | -9.0% | +97.1% | -54.6% | |
| – | +44.0% | +34.4% | -59.4% | +21.7% | +8.2% | -6.0% | -7.7% | +4.6% | +14.0% | +19.8% | -32.5% | +37.6% | -52.9% | +0.0% | -16.0% | -45.3% | -19.4% | +276.0% | -27.8% | -43.2% | +129.6% | +64.3% | -19.2% | +12.4% | +241.0% | -45.5% | |
| – | +111.7% | -69.9% | +47.8% | -20.0% | +23.6% | -10.7% | -98.0% | – | – | – | – | – | – | – | -4.8% | -100.0% | – | +0.0% | +740.0% | -100.0% | – | – | – | -2.4% | -64.7% | -37.5% | |
| – | +32.3% | +30.5% | -57.6% | +31.6% | -47.3% | +84.6% | -57.8% | +57.1% | -5.5% | -17.4% | -10.9% | +152.5% | -87.0% | +342.2% | -97.8% | +845.1% | -33.1% | +143.9% | +12.7% | -25.4% | +61.3% | +11.8% | -19.5% | -43.8% | +430.7% | +24.1% | |
| – | – | -11.3% | +6.4% | -16.2% | -50.7% | -97.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.0% | +92.9% | -47.6% | -21.8% | +14.8% | +18.2% | -24.9% | -4.3% | -24.5% | -22.8% | -52.7% | -60.5% | +15.7% | +0.0% | -70.5% | +2,856.5% | -24.0% | -25.3% | -24.1% | -26.2% | -0.5% | +168.0% | -51.7% | -34.1% | -183.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +48.9% | +4,946.0% | -97.8% | +0.5% | +5,648.2% | -98.2% | +0.4% | +0.4% | +0.0% | +4.3% | +0.4% | +4,648.9% | +0.3% | +0.0% | -96.8% | +50.8% | +79.3% | +9.5% | +3.4% | +18.9% | +27.0% | +54.4% | +12.6% | +39.1% | +30.1% | +128.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.